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Abstract
Background: The mechanisms of cerebellar degeneration attributed to prolonged and excessive alcohol intake
remain unclear. Additional or even alternative causes of cerebellar degeneration are often overlooked in suspected
cases of alcohol-related ataxia. The objectives of this study were two fold: (1) to investigate the prevalence of gluten-
related serological markers in patients with alcohol-related ataxia and; (2) to compare the pattern of brain
involvement on magnetic resonance imaging between patients with alcohol and gluten ataxias.
Materials & Methods: Patients diagnosed with alcohol and gluten ataxias were identified from a retrospective review
of patients attending a tertiary clinic. HLA genotype and serological markers of gluten-related disorders were
recorded. Cerebellar volumetry, MR spectroscopy and voxel-based morphometric analyses were performed on
patients and compared with matched control data.
Results: Of 904 registered patients, 104 had alcohol ataxia and 159 had gluten ataxia. 61% of the alcohol ataxia
group and 70% of the gluten ataxia group had HLA DQ2/DQ8 genotype compared to 30% in healthy local blood
donors. 44% of patients with alcohol ataxia had antigliadin antibodies compared to 12% in the healthy local
population and 10% in patients with genetically confirmed ataxias. None of the patients with alcohol ataxia and
antigliadin antibodies had celiac disease compared to 40% in patients with gluten ataxia. The pattern of structural
brain abnormality in patients with alcohol ataxia who had antigliadin antibodies differed from gluten ataxia and was
identical to that of alcohol ataxia.
Conclusions: Alcohol related cerebellar degeneration may, in genetically susceptible individuals, induce
sensitization to gluten. Such sensitization may result from a primary cerebellar insult, but a more systemic effect is
also possible. The duration and amount of exposure to alcohol may not be the only factors responsible for the
cerebellar insult.
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Introduction
Previous studies have shown that patients with chronic
alcohol abuse often have elevated serological levels of
antibodies directed towards self-antigens as well as elevated
IgA immunoglobulins and T-cells[1]. High levels of
immunoglobulins can be seen in immune mediated
diseases[2]. Recently, excessive alcohol consumption has
been shown to mediate an IgA immune response, which is not
only directed towards alcohol-derived neo-antigens but also
against tissue transglutaminase[3]. Transglutaminases
constitute a family of enzymes with cross-linking capability[4].
Tissue transglutaminase 2 (TG2) and TG3 have been
implicated as the autoantigens in celiac disease[5] and
dermatitis herpetiformis respectively[6]. Recently, antibodies
against TG6 were found in patients with gluten ataxia (GA –
defined as idiopathic sporadic ataxia with positive antigliadin
antibodies)[7]. Individuals with GA (and other gluten-related
disorders) show genetic susceptibility, with almost all patients
demonstrating the HLA-DQ2/DQ8 genotype[8,9].
The presence of TG2 antibodies (the autoantigen of celiac
disease) in patients with chronic alcoholism raises the
possibility of alcohol-induced sensitivity to gluten. One potential
mechanism recently proposed is that alcohol-induced intestinal
mucosal lesions increase gut permeability and may lead to the
exposure of new antigens, (such as gliadin peptides), which
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are considered foreign by the mucosal system[3]. A
compromise to the blood brain barrier (such as is thought to
occur in gluten ataxia[10] and alcohol abuse[11]) could
theoretically, expose the brain to antibodies or immune
complexes and lead to/potentiate neurological damage.
Both gluten-related diseases and alcohol are known to affect
the cerebellum, an organ that shows particular vulnerability to
immune-mediated damage. Indeed, a number of conditions
exist that are associated with immune-provoked cerebellar
damage such as, paraneoplastic cerebellar degeneration, post-
infectious cerebellitis, Miller-Fisher syndrome, opsoclonus-
myoclonus ataxia and ataxia with anti-GAD antibodies[12].
Many of these conditions are associated with autoantibodies
that target and react with Purkinje cells causing their loss and
permanent disability (ataxia) for the patient[12,13]. Recent
evidence also suggests the internalization of circulating
immunoglobulins by Purkinje cells in the setting of blood brain
barrier disruption[14,15].
Given that gluten exposure (in cases with GA) and alcohol
are known to cause cerebellar degeneration, it may be difficult
to establish the primary cause of the cerebellar insult in any
patient that demonstrates co-existence of the two conditions.
The primary aim of this study was to investigate the
prevalence of serological evidence of sensitivity to gluten and
HLA-status in patients with ataxia presumed to be due to
chronic alcohol abuse (ACAA). The secondary aim was to
compare the pattern of cerebellar involvement using magnetic
resonance (MR) imaging between patients with GA and
patients with ACAA (with and without serological evidence of
sensitivity to gluten).
Materials & Methods
Subjects and Controls
The study was approved by the local, regional ethics
committee (Leeds Central) and all participants gave their
written informed consent prior to inclusion in compliance with
the Code of Ethical Principles for Medical Research Involving
Human Subjects of the World Medical Association (Declaration
of Helsinki).
A retrospective review of all patients attending the ataxia
clinic, Royal Hallamshire Hospital, Sheffield, UK was
performed. Patients with a diagnosis of GA and ACAA were
sought. This clinic was established 15 years ago and cares for
over 900 patients with progressive ataxia. Patients are
reviewed on a regular basis and have undergone extensive
investigations to establish the cause of their ataxia. A
diagnostic breakdown of these patients is available in the
literature[16] but briefly consists of both familial (183/900) and
sporadic (717/900) ataxia groups. Patients with familial ataxia
included episodic ataxia (types 1 and 2), spinocerebellar ataxia
(types 1, 2, 3, 6, 7, 8, 13, 15, 17, 28), Friedreich’s ataxia,
Niemann-Pick disease, familial British dementia, mitochondrial
encephalopathy lactic acidosis and stroke-like episodes,
Gerstmann-Staussler-Scheinker syndrome and polymerase
gamma. Patients with sporadic ataxia largely consisted of
idiopathic sporadic ataxia, gluten ataxia, alcoholic cerebellar
degeneration, clinically probable multiple system atrophy,
paraneoplastic ataxia, and drug-induced ataxia. GA is defined
as an idiopathic sporadic ataxia with positive antigliadin
antibodies[17]. A diagnosis of ACAA was based upon positive
clinical history of chronic alcohol excess with hematological/
serological evidence of alcohol excess (raised gamma-GT and
mean corpuscular volume) in the absence of an alternative
explanation for the ataxia. All patients from the two groups that
had undergone the exact same MR imaging protocol of the
brain (see below) were selected. The clinical notes of these
patients were then assessed to obtain the duration and severity
of ataxia symptoms at the time of MR imaging. Ataxia severity
was classified as mild, moderate or severe as assessed by the
same experienced consultant neurologist (MH) and adapted
from previously published data[18]. Briefly the scale comprised:
mild – instability without staggering steps or falls; moderate –
instability with staggering steps or falls and/or requires support
through a walking aid and; severe – unable to walk despite
support from an accompanying person.
HLA-DQ2/DQ8 serological status of both groups was
obtained, as was the presence of antigliadin antibodies in the
ACAA group at the time of MR. Evidence of celiac disease (in
the form of positive duodenal biopsies) was also sought in both
patient groups. The presence of antigliadin antibodies allowed
subdivision of the ACAA group in to those with (ACAA+) and
those without (ACAA-) serological evidence of gluten
sensitivity.
Healthy volunteers, recruited for research, were selected for
age- and sex-matching from a database of 55 subjects that had
undergone the same MR imaging protocol as detailed below.
Subject details have been extensively reported in the
literature[19].
MR Imaging Outcome Measures
Outcome measures comprised of: (a) cerebellar volume,
expressed as a percentage of total intracranial volume
(%CV:TIV); (b) spectroscopic N-acetyl aspartate to creatine
(NAA/Cr) and Choline to creatine (Cho/Cr) ratios in the
cerebellar vermis and hemisphere and; (c) grey matter ‘density’
as indicated by grey matter voxel-based morphometry. Data
from each subject group were compared to control data
matched for age and sex.
Imaging Protocol
Scanning was performed at the Academic Unit of Radiology,
University of Sheffield using a 3-T system (Philips ACHIEVA
3.0T Best, Netherlands) with an 8-channel receive only array
head coil.
Structural MR imaging comprised high-resolution 3-
dimensional T1-weighted MR imaging datasets acquired using
a magnetization-prepared rapid gradient echo sequence (TR =
11 ms, TE = 4.8 ms, TI= 1400 ms, flip angle = 8°, volume-of-
view = 256 x 205 x 150 mm3, voxel dimension = 0.8 mm
isotropic, acquisition time = 5 min 32 sec).
1H-MR spectroscopy comprised a point-resolved
spectroscopy (PRESS) sequence (TR = 2000 ms, TE = 144
ms; 128 measurements; 1024 spectral points; spectral
bandwidth 2000Hz) with data acquired at two voxel positions.
Each voxel comprised a parallelepid of 2.0 X 1.0 X 2.0 cm3 (4
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mL) placed over the superior cerebellar vermis and the deep
cerebellar white matter of the right cerebellar hemisphere. Care
was taken to avoid inclusion of cerebrospinal fluid spaces
within the volume of interest. (Figure 1) After automated higher-
order shimming, water suppression was achieved using a
chemical shift selective imaging pulse technique (CHESS).
Post-processing of the spectra involved the following steps:
zero filling, gaussian filtering, exponential multiplication, Fourier
transform and manual phase correction with baseline
subtraction. Fitted-peak integral values for N-acetylaspartate
(NAA) and choline (Cho) were referred to the peak integral
value of creatine (Cr) as the internal reference using the MR
system manufacturer’s proprietary software. NAA/Cho data
was also assessed.
Decision regarding the quality of cerebellar spectroscopy
was made by consensus opinion between two
neuroradiologists (NH/SC) and was based on criteria published
previously in the literature[20]. Briefly, this comprised
assessment of signal to noise ratio, peak shape and separation
of choline (Cho) and creatine (Cr) peaks. Patients with poor
quality cerebellar MR spectra were excluded.
Structural Imaging Analysis
a): Whole brain and cerebellar volume analysis.  Brain
tissue volume, normalized for subject head size, was estimated
with Structural Image Evaluation, using Normalization, of
Atrophy cross-sectional method (SIENAX)[21,22], part of
FSL[23–27].
Cerebellar segmentation was obtained in the following
manner using FSL. Firstly, a cerebellum segmentation template
was obtained from a standard template image using an
Integrated Registration and Segmentation Tool (FIRST)[28].
The template image was then registered using FMRIB’s Non-
linear Image Registration Tool (FNIRT). Invwarp was used to
invert the FNIRT warp and transfer the segmentation from the
Figure 1.  Cerebellar voxel placement.  Location of 1H MR
spectroscopy voxel within the right cerebellar hemisphere (top
row) and superior vermis (bottom row).
doi: 10.1371/journal.pone.0077638.g001
template space to the subject’s space. For all subjects and
controls cerebellar volume (CV) (calculated from binarised data
of the segmented cerebellum) was expressed as a ratio of total
intracranial volume (TIV) to allow for variation in individual head
size.
b): Grey matter voxel-based morphometry.  Structural
data was analyzed with FSL-VBM, a voxel-based morphometry
style analysis[29,30] carried out with FSL tools[23]. The
following method has been previously published in the
literature[31]. First, structural images were brain-extracted
using BET[24]. Next, tissue-type segmentation was carried out
using FAST4[27]. The resulting grey-matter partial volume
images were then aligned to MNI152 standard space using the
affine registration tool FLIRT[25,26], followed by nonlinear
registration using FNIRT, which uses a b-spline representation
of the registration warp field[32]. The resulting images were
averaged to create a study-specific template, to which the
native grey matter images were then non-linearly re-registered.
The registered partial volume images were then modulated (to
correct for local expansion or contraction) by dividing by the
Jacobian of the warp field. Finally the modulated segmented
images were then smoothed with an isotropic gaussian kernel
having a sigma of 3 mm[33].
Statistical Analysis
Any difference in mean %CV:TIV between subjects and
controls was assessed using an Independent-Samples Mann-
Whitney U Test (SPSS software (SPSS, Inc.)). This method
was also applied to examine any statistical differences in mean
NAA/Cr and Cho/Cr ratios of the cerebellar hemisphere and
vermis between subjects and controls. Bonferroni correction
was applied to allow for multiple comparisons. Age- and sex-
matched control groups were obtained for both GA and ACAA
cohorts. To investigate grey matter density changes, we used
permutation-based non-parametric inference within the
framework of the general linear model (5000 permutations)
through FSL[34]. Results were considered significant for
P<0.05, fully corrected for multiple comparisons (i.e.
automatically controlling for family-wise error rate)[34].
Results
Over a 15-year period, 904 patients with progressive
cerebellar ataxia attended the specialist ataxia clinic at the
Royal Hallamshire Hospital, Sheffield, UK. Of these, 104
(11.5%) patients were diagnosed with ACAA and 159 (17.6%)
patients with GA.
61% of the ACAA group and 70% of the GA group had the
HLA DQ2/DQ8 genotype, compared to 30% in healthy local
blood donors[35]. 44% of patients with ACAA had antibodies to
gliadin (IgG and/or IgA) compared to 12% in the healthy local
population and 10% in patients with genetically confirmed
ataxias[36,37]. None of the patients with ACAA and antigliadin
antibodies had celiac disease on duodenal biopsy compared to
40% of patients with GA who had enteropathy on biopsy. None
of the patients with GA had raised MCV or gamma GT.
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Twenty-nine patients with ACAA and 17 patients with GA
underwent the previously detailed, same MR imaging protocol.
Table 1
MR Spectroscopy
Patients with ACAA vs. controls.  Vermian NAA/Cr was
significantly reduced in patients with ACAA (0.86 ± 0.11)
compared to age- and sex-matched controls (0.97 ± 0.05), CI
95% 0.05 to 0.16; p <0.001. No statistically significant
difference was found between patients with ACAA and controls
for vermian Cho/Cr (p=0.73) and cerebellar hemispheric
NAA/Cr (p=0.19) and Cho/Cr (p=0.37).
Patients with GA vs. controls.  Vermian NAA/Cr was
significantly reduced in patients with GA (0.77 ± 0.11)
compared to age- and sex-matched controls (0.96 ± 0.07), CI
95% 0.12 to 0.25; p <0.001. No statistically significant
difference was found between patients with GA and controls for
vermian Cho/Cr (p=0.13) and cerebellar hemispheric NAA/Cr
(p=0.63) and Cho/Cr (p=0.39).
Patients with GA vs. patients with ACAA.  Using group
data as depicted in Table 1 (i.e. unmatched for symptom
duration), vermian NAA/Cr was significantly reduced in patients
with GA (0.77 ± 0.11) compared to patients with ACAA (0.86 ±
0.11), CI 95% 0.02 to 0.16; p <0.05. When patients were
matched for symptom duration (GA n=11, ACAA n=17; median
8 years from symptom onset to MR; mean age 52±7 years for
both groups; mean ataxia severity GA=1.6, AA=1.5) there was
an overall trend for reduced vermian NAA/Cr in the GA group
compared to ACAA but this failed to reach statistical
significance (0.79 vs. 0.87 respectively, CI 95% -0.19 to 0.03,
p>0.05).
Table 1. Patient demographic data according to subject
group*.
Subject group
Mean age (SD
and range) at
MRI (yrs.) M:F
Median duration of
symptoms at MRI
(yrs.)
Mean ataxia
severity score
(1=mild,
2=moderate,
3=severe)
GA (n=17) 52±10 (33-67) 5:12 10 (range 3-16) 1.9
ACAA
(n=29) 54±8 (39-69) 17:12 6 (range 1-10) 1.7
ACAA+
(n=10) 49±8 (39-62) 5:5 5 (range 1-10) 1.7
ACAA-
(n=19) 56±8 (41-69) 12:7 8 (range 2-10) 1.7
*. Controls underwent the exact same MR imaging protocol as the patient groups.
Controls were matched to patients within each group according to age and gender
from a pool of 55 healthy volunteers. Control demographics matched to the GA
group: n = 17, M:F = 5:12, mean age at MRI = 52±10 (33 to 68) and; for the ACAA
group: n = 29, M:F = 17:12, mean age at MRI = 55±8 (41 to 68). No statistically
significant differences in age were found across the ACAA, GA and control groups
(p = 0.74, Kruskal-Wallis test).
doi: 10.1371/journal.pone.0077638.t001
No statistically significant differences were found in vermian
Cho/Cr (p=0.10/p=0.20) or cerebellar hemispheric NAA/Cr
(p=0.30/p=0.23) and Cho/Cr (p=0.64/p=0.78) between patients
with GA and patients with ACAA irrespective if the data were
unmatched or matched for symptom duration (p values shown
= unmatched/matched data).
Comparing MR spectroscopy data from GA with ACAA- and
GA with ACAA+ revealed no statistical significant differences in
neurometabolite ratios at either voxel position irrespective of
matching for symptom duration. Similarly, no statistically
significant differences were found in the neurometabolite ratios
when ACAA- and ACAA+ groups were compared directly,
irrespective of voxel position and matching for symptom
duration.
Cerebellar Volume
Patients with ACAA vs. controls.  Cerebellar volume (as a
percentage of total intracranial volume) was significantly
smaller in patients with ACAA (5.95 ± 0.79) compared to age-
and sex-matched controls (8.85 ± 1.11); CI 95% 2.26 to 3.53,
p<0.001.
Patients with GA vs. controls.  Cerebellar volume was
significantly smaller in patients with GA (4.71 ± 1.20) compared
to age- and sex-matched controls (8.46 ± 1.06); CI 95% 2.96 to
4.54, p<0.001.
Patients with GA vs. patients with ACAA.  Cerebellar
volume was significantly smaller in patients with GA (4.71 ±
1.20) compared to patients with ACAA (5.95 ± 0.79); CI 95%
0.57 to 1.93, p<0.001. Statistical significance was maintained
when patients were matched for duration of symptoms (GA
n=11; ACAA n=17; %CV:TIV = 4.90 ± 1.28 vs. 5.83 ± 0.78
respectively; CI 95% 0.13 to 1.72, p<0.05 - median duration of
symptoms 8 years; mean ataxia severity score GA 1.6, ACAA
1.5, mean age both 52 ± 7 years).
Cerebellar volume was significantly smaller in patients with
GA compared to patients with ACAA- (4.71 ± 1.20 vs. 5.60 ±
1.64; CI 95% 0.49 to 1.90, p<0.05). Although the trend for
smaller cerebellar volume in the GA group (compared to
ACAA-) continued when patients were matched for duration of
symptoms, data failed to reach statistical significance (p =
0.07). Similarly, when cerebellar volume in patients with GA
was compared with that of ACAA+ no statistical significance
was demonstrated irrespective of matching for symptom
duration (p = 0.19/0.62; unmatched/matched for symptom
duration).
No statistically significant difference in cerebellar volume was
found between ACAA+ and ACAA- irrespective of matching for
symptom duration (p = 0.11/0.39; unmatched/matched for
symptom duration).
Grey Matter VBM
Voxel-based morphometry demonstrated reduced grey
matter volume in both patient groups compared with controls.
This constituted pure cerebellar atrophy in the GA group but
cerebellar atrophy in combination with supratentorial
involvement in the ACAA group. Analysis of just the ACAA+
group compared with controls showed a similar pattern of
atrophy to that of the ACAA group. Figure 2
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Figure 2.  Grey matter voxel-based morphometry.  Areas of reduced grey matter density (depicted on the MNI152 brain)
compared to age- and sex-matched controls using voxel based morphometry (highlighted areas, corrected, p<0.05).
A) Patients with GA show pancerebellar grey matter reduction. B) Patients with ACAA show cerebellar hemispheric grey matter
reduction as well as cingulate gyrus and inferior frontal lobe involvement. C) Patients with ataxia due to chronic alcohol abuse that
also demonstrate sensitivity to gluten. Note this is the same pattern of disease as shown in patients with ACAA (B) and differs to
that of GA(A).
doi: 10.1371/journal.pone.0077638.g002
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Discussion
The primary aim of this study was to investigate the
prevalence of serological evidence of sensitivity to gluten and
HLA-status in patients with ataxia presumed to be due to
chronic alcohol abuse (ACAA). The secondary aim was to
compare the pattern of cerebellar involvement using MR
imaging between patients with GA and patients with ACAA
(with and without serological evidence of sensitivity to gluten).
We specifically targeted the superior cerebellar vermis on MR
spectroscopy as this is a site known to be affected by both
diseases[38,39]. Until now, a measurement of the prevalence
of gluten sensitivity in patients with ACAA was unavailable in
the medical literature. Additionally, we know of no previous
reports in the literature that have quantified in vivo cerebellar
volume and that have performed voxel based morphometry to
characterize grey matter loss in both patient cohorts.
This study demonstrates that the prevalence of antigliadin
antibodies in patients with ACAA is significantly higher than in
control groups (44% vs. 12% in the healthy population[36] and
10% in hereditary ataxias[39]). Furthermore, the prevalence of
the HLA-DQ2/DQ8 genotype in patients with ACAA is more
than double that of the healthy population (61% vs. 30%[35]).
This study also demonstrates that compared to age- and sex-
matched controls, patients with ACAA and GA have significant
structural and functional cerebellar deficits. NAA is considered
a marker of neuronal health and integrity. Accordingly, reduced
NAA/Cr levels are typically attributed to neuronal dysfunction or
loss. Our MR spectroscopy findings are in agreement with the
published literature[40–42].
Voxel-based morphometry analysis reveals that GA and
ACAA have different radiological phenotype with respect to
grey matter loss. Patients with GA show considerable grey
matter loss, which appears to be confined to and involves most
of the cerebellum. Conversely, patients with ACAA have more
modest cerebellar involvement but the disease extends into the
supratentorial compartment. Our finding of reduced grey matter
density in the anterior cingulate gyrus in patients with ACAA is
in agreement with reports of regional volume loss in alcohol
dependents and has been linked to dysfunction in the brain
reward system in those individuals[43].
One particular question arising from this study concerns the
origin of antigliadin antibodies in patients with ACAA. The high
prevalence of antigliadin antibodies together with the high
prevalence of HLA-DQ2/DQ8 suggests that this is more than
just an epiphenomenon. The differing pattern of brain
abnormality between patients with GA and ACAA on voxel
based morphometry suggests that in the case of ACAA,
antigliadin antibodies may arise after a cerebellar insult rather
than being the cause of it per se. It also implies that there is a
genetic susceptibility (HLA DQ2) for patients with ACAA,
something that has not previously been reported. The HLA
DQ2 has also been seen in a number of other autoimmune
diseases including primary autoimmune cerebellar ataxia. This
raises the issue that autoimmunity may have a role to play in
the development of ataxia in patients that drink excessively.
The lack of histological evidence of celiac disease in patients
with ACAA despite positive antigliadin antibodies as compared
to the 40% prevalence of celiac disease in patients with gluten
ataxia (all positive for antigliadin antibodies) appears to provide
an argument against the gastrointestinal tract being the primary
source of the immunological response. A possible explanation
may be that antigliadin antibodies arise in patients with genetic
susceptibility (HLADQ2/DQ8 genotype) following a chronic
immunological insult (alcohol) centered on the cerebellum.
Alcohol has previously been associated with antibodies to
transglutaminase and is known to evoke an immunogenic
reaction[3].
The role of tissue specific transglutaminases (i.e. TG2 in
celiac disease, TG3 in dermatitis herpetiformis and TG6 in GA)
in ACAA remains to be explored. TG6 is a primarily brain
expressed TG and antibodies to TG6 have been found in the
serum and in the cerebellum of patients with GA[7].
This study is limited by the relatively small sample size. It is
also retrospective and as such has inherent limitations.
Antigliadin antibodies were used as evidence for sensitivity to
gluten simply because currently there are no sensitive
serological markers for the whole spectrum of gluten-related
disorders. We have not examined whether patients had co-
existing alcoholic liver disease and also have not compared the
data with a cohort of patients with alcoholic liver disease
without ataxia. As such we have not discounted the possibility
that liver disease per se may be a risk factor for serological
positivity for gluten-related antibodies rather than being
mediated through a prolonged cerebellar insult. Kril and
Butterworth looked at formalin-fixed sections of the anterior
superior aspect of the cerebellar vermis in 36 patients (30
alcoholic and 6 nonalcoholic) with autopsy-proven cirrhosis and
found cerebellar degeneration in 20 cases (17 alcoholic and 3
nonalcoholic patients). The degree of Purkinje cell loss and
gliosis was graded as mild in all 3 nonalcoholic patients
(compared to 8 mild, 6 moderate and 3 severe for the alcoholic
group). The authors raised the possibility that liver disease-
related mechanisms may contribute to cerebellar pathology but
this is still to be confirmed[44]. Floreani et al. examined the
prevalence of antigliadin antibodies in 67 patients with chronic
liver disease of different aetiology, including 29 with primary
biliary cirrhosis, 31 with chronic non-A non-B hepatitis, and 7
with autoimmune chronic active hepatitis. Overall, low
prevalence of IgA antigliadin antibodies was observed in the
three patient groups (3.4% primary biliary cirrhosis, 3.2% non-
A, non-B hepatitis compared to 1.3% of patients with
inflammatory bowel disease). One patient with autoimmune
chronic active hepatitis had raised IgA and IgG antigliadin
antibodies and subsequent jejunal biopsy confirmed celiac
disease. Not all patients had small bowel biopsy and no
neurological correlation was investigated[45]. Germenis and
colleagues retrospectively assessed the prevalence of tissue
transglutaminase (IgA tTGAbs) in 738 patients with chronic
liver diseases and compared data to that from 1,350 healthy
controls. The overall prevalence of tTGAb in the patient group
was 6.4% - significantly higher compared to 0.3% of healthy
controls. Aetiology of liver disease was proven not to be a
significant risk factor for the detection of tTGAbs (prevalence of
tTGAb in patients with alcoholic liver disease 7.8%,
nonalcoholic fatty liver disease 8.2%, chronic viral hepatitis
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4.3% and autoimmune hepatitis 12%). Only 2 patients were
diagnosed with celiac disease compared to 4 in the healthy
controls. The authors concluded that IgA anti-tTG reactivity in
patients with chronic liver diseases is not associated with celiac
disease but appears to be associated with the presence of an
autoimmune phenomena and cirrhosis. However, only 29
patients (of the 46 that tested positive for tTGAbs) underwent
small bowel biopsy and celiac disease was confirmed in 2 (all 4
healthy controls with raised tTGAbs had biopsy confirmed
celiac disease). HLA typing was also limited. Additionally, the
presence of neurological dysfunction was not examined[46].
Future prospective studies examining the prevalence of
serological evidence (including TG6) of gluten-related disorders
in a cohort of patients with alcoholic liver disease would be of
interest as abnormal liver function tests and autoimmune
hepatitis are over-represented in patients with celiac disease.
Research examining cerebrospinal fluid for any evidence of
intrathecal antibodies to transglutaminases as well as evidence
of oligoclonal bands and compromise to the blood brain barrier
in these patients would also be of interest.
In summary, this study demonstrates that patients with
alcoholic ataxia have a high prevalence of antigliadin
antibodies in combination with a high prevalence of the HLA-
DQ2/DQ8 genotype, strongly associated with gluten-related
disorders. The pattern of cerebellar involvement in alcoholic
ataxia differs from that observed in patients with GA. This
raises the possibility that alcohol excess in genetically
susceptible individuals may induce sensitization to gluten
rather than these being cases of GA.
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